Are peptides legal in Egypt?

The Egyptian Drug Authority (هيئة الدواء المصرية) was set up by Law 151 of 2019, in force since February 2020, with its executive regulation in Prime Minister's Decree 777 of 2020. Its drug database covers human medicines, biological products, herbal and veterinary medicines, biocides, cosmetics and complementary products. Its list of the laws it works under includes Law 127 of 1955 on the practice of pharmacy and Law 182 of 1960 on narcotic drugs. Website: edaegypt.gov.eg. Hotline: 15301, 24 hours a day.

The EDA's guide for synthetic peptide medicines is the Regulatory Guideline on the Registration of Synthetic Peptides Human Pharmaceutical Products that refer to a Reference Peptide Product of rDNA Origin, EDREX:GL.CAPP.036, version 4, issued 13 October 2025. In short:

• It covers generic synthetic peptides that copy a reference medicine first made by recombinant DNA technology, made in Egypt or imported. Version 3 (March 2025) added the import route.
• It defines synthetic peptides as alpha amino acid polymers of 40 or fewer amino acids.
• Its questions and answers name the reference medicines in view: glucagon and glucagon-like peptides such as semaglutide; liraglutide; nesiritide; teriparatide; and teduglutide. The same approach, it says, can be used for other synthetic peptides, such as tirzepatide.
• A company needs naming approval, a pharmacovigilance review and a pricing certificate, makes three batches in front of an EDA inspector, then files a full dossier. Even the raw material needs EDA import approval, and an imported medicine's first shipment waits for the EDA's own analysis.

On 6 November 2026 the EDA added that tirzepatide is the active ingredient of a medicine registered with it, but that no product is registered under the name "Tirzepatide" on its own (Parlmany, 6 November 2026).

Registered medicines reach pharmacies through the licensed pharmaceutical chain, not through research suppliers. Our page for pharmaceutical companies and distributors explains what we can and cannot do for them.

The EDA's cosmetics registration guide (version 1, 2020) defines a cosmetic as a product for the outer parts of the body, the teeth or the lining of the mouth, used to clean, perfume, protect, keep in good condition, change appearance or correct body odour. Cosmetics, local or imported, may not be sold or imported until registered. Since 6 March 2023 the filing is an electronic notification, under EDA Chairman's Decree 122 of 2022. The rules are Ministerial Decree 151 of 2015 and the European cosmetic requirements; the file lists every ingredient by INCI name with its percentage, and gives a scientific reference for each claim on the pack.

Peptides such as copper tripeptide-1 are ordinary cosmetic ingredients. We supply cosmetic-grade peptides to manufacturers and brands; the brand registers or notifies the finished product. Registering a cosmetic product in Egypt covers the file.

A research material is a substance sold to a laboratory for experiments. We have found no EDA rule, guide or statement on research-use-only materials or laboratory reagents. Our position, which is for an Egyptian lawyer to confirm:

• A research material is not a medicine and is not for use in people or animals.
• We sell research-grade products only to businesses and institutions we have verified, against a signed end-use declaration. We do not supply individuals.
• None of our pages describes what a product does in a body or gives a dose.

That position is for an Egyptian lawyer to confirm. Research use only, explained covers the label, and who can buy from us lists our checks. One point is clear already: a "research use only" line does not make a sale to the public lawful.

• August. Reported as saying it had approved only two slimming injections, and that buyers should check the registration number on the pack (Al Khaleej, 19 August).
• 22 September. A warning against capsules sold as tirzepatide on social media (Youm7).
• 28 September. A warning against an online shop trading under a "peptides" name that sold slimming and fat-burning products, which it described as of unknown source, counterfeit, and not registered or approved by the official regulators. The EDA said the products made deceptive therapeutic claims and that it would take all legal measures against those running such sites. We do not name the shop; Youm7's report does.
• 30 September. Notices against unapproved medicines advertised on Facebook, Instagram and TikTok (Egyptian Streets, 30 September).
• October and November. More warnings against unregistered slimming products on social media, including products claimed to contain retatrutide, also sold as "Reta". The EDA said these are not registered with it, that retatrutide is still in clinical trials without approval to be sold as a treatment, and that products of unknown source may contain unidentified ingredients, contaminants or the wrong amount of active substance (Masrawy, 21 October; Parlmany, 6 November; Youm7, 10 November).

Its advice across these warnings: check a product's registration on the EDA's website; buy medicines only from licensed pharmacies; do not rely on social media advertisements, and see a specialist doctor before starting treatment; report suspect products on 15301 or through the "inappropriate advertisement" service on its website.

The EDA's guide to its Egyptian Drug Database (EDREX:NP.PPMA.18, 6 June 2024) says the database, on edaegypt.gov.eg, shows every valid registered pharmaceutical product in Egypt:

1. Choose the product type, for example human pharmaceutical or cosmetics.
2. Enter a trade name, registration number, applicant or generic name.
3. Type the verification code and search.
4. Press "View" for the registration number, registration and expiry dates and applicant, and, for medicines, the licence status, price status and storage condition.

It tells you whether a product with that name or number is registered, and to whom. It cannot tell you whether the pack in front of you is genuine, or whether the seller may sell it: buy from a licensed pharmacy, compare the registration number on the pack, and call 15301 if anything does not match. We describe the tool from the EDA's guide; the live page may look different.

Import. Under the EDA's peptide guide, even a registered manufacturer needs EDA approval to import its raw material. A law firm's guide (Legal500) says importing pharmaceuticals and their raw materials needs an EDA registration or a pending one, prior EDA approval, and a registered importer; we have not checked that against the law itself. We have found no rule on importing research materials; how we handle it is for an Egyptian lawyer to confirm. We deliver to your business address in Egypt.

Penalties. We have not found the penalty articles of Law 151 of 2019 in a text we can cite, so we quote none. The EDA has promised legal action against sellers, and its list of laws includes Decree 4042 of 2026.

Travel. For people leaving Egypt, the EDA's alert of 13 January 2026 says to check the destination's rules, carry a recent certified prescription naming the medicine and the condition, and carry only what the trip needs. Its personal export service approves medicines taken abroad against a prescription, for up to three months' treatment, excluding narcotics and internationally controlled substances. On bringing medicines into Egypt we found no EDA statement we can cite: ask the EDA on 15301, or a lawyer, before you travel.